Kura Oncology, Inc. (KURA) NASDAQ
8.97
-0.065(-0.72%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.97
-0.065(-0.72%)
Currency In USD
| Market Cap | 910.95M |
| Enterprise Value | 782.31M |
| P/E Ratio | -2.7 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 11.12 |
| Price/Book Ratio | 7.37 |
| Enterprise/Revenue | 10.91 |
| Enterprise/EBITDA | -2.62 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -4.11 |
| Operating Margin | -4.44 |
| Return On Assets | -0.45 |
| Return On Equity | -1.42 |
| Revenue | 67.48M |
| Revenue/Share | 0.81 |
| Gross Profit | 67.43M |
| EBITDA | -275.83M |
| Net Income | -278.67M |
| Diluted EPS | -3.18 |
| Total Cash | 580.82M |
| Total Cash/Share | 6.55 |
| Total Debt | 24.27M |
| Total Debt/Equity | 0.22 |
| Current Ratio | 6.15 |
| Book Value Per Share | 1.22 |
| 52-Week Change | 42.38 |
| 52-Week High | 12.49 |
| 52-Week Low | 5.45 |
| Moving Average 50 Days | 9.17 |
| Moving Average 200 Days | 9.28 |
| Average Volume | 1.64M |
| Shares Outstanding | 88.77M |
| % Held by Institutions | 95.83 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |